THE HEALTH CAPTAINS COLLEGE
Governance Academy
Scientific Advisory Boards Division
Purpose
Scientific Leadership in the Era of SuperConvergence
To equip members of scientific advisory boards with the interdisciplinary foresight, translational insight, and ethical compass necessary to advise on the accelerating superconvergence of technologies and science—enabling sustainable value-based healthcare, healthy longevity for all, and community-driven transformation grounded in the principles of Blue Zones and One Health Lifecare.
CURRICULUM
Curriculum Structure
Duration: Modular – (Hybrid: In-person + Digital) & Format:
Executive Modules
Interdisciplinary foresight labs
Translational case studies
Science-to-governance simulation workshops
Final Capstone: Scientific Foresight & Governance Brief
Core Modules
Module 1:
The Role of Scientific Advisory Boards in Lifecare Innovation
Mission, ethics, and influence of scientific advisory boards
Translating science to strategy, policy, and innovation
Cross-sector collaboration and academic–industry interfaces
Scientific leadership as a driver of sustainable health systems
Outcome: Establish the board’s strategic role as a bridge between scientific insight and systems transformation.
Module 2:
The SuperConvergence of Technology in Medicine
Framing the SuperConvergence (based on Eric Topol and beyond)
Genomics to Nanomedicine: The New Biomedical Continuum
Intersections of computation, biology, robotics, and society
Risks, Governance Gaps, and the Ethics of accelerated Innovation
- The Health Captains Hippocratic Oath and Nobel Forum on Doctors Island Kos – Greece
Outcome: Equip advisors to understand and shape the converging technological frontiers of health and medicine.
Module 3:
Precision Medicine & Precision Science
From population averages to individualized care
- The Human Genomics Project and molecular multi-omics Precision Medicine
Single-cell sequencing, multi-omics molecular n-of-1 profiling, and digital phenotyping
Human Cell Atlas Project and in-silico Medicine
- The Human Phonemics Project invented by Leroy Hood et al for Precision Health
Governance of R&D pipelines, validation, and clinical translation
Outcome: Enable oversight of precision health innovations across scientific, clinical, and policy dimensions.
Module 4:
Data, AI & Digital Bioethics
Big data ecosystems and cloud-based infrastructures
AI in diagnostics, therapeutics, and research acceleration
Cybersecurity, privacy, and data ownership
Blockchain, transparency, and scientific integrity
Outcome: Strengthen board-level capabilities in ethical digital transformation and responsible data governance.
Module 5:
From Sickcare to Sustainable Lifecare – the Transformation from
“The Sickspan Economy” towards “The Healthspan Economy”
- The Healthy Longevity Challenge by the National Academy of Medicine
Scientific foundations of Healthy Longevity
- The Healthy Longevity Medicine Umbrella
Biomarkers of Aging and Regenerative Medicine
Translational convergence models for Blue Zones-inspired Community Care
- Building an scaleable & sustainable Healthy Longevity Ecosystem
Global equity, health justice, and science diplomacy
- Knowledge: Healthspan Medicine & Healthspan Science towards “The Healthspan Economy”
Outcome: Position scientific advisors as stewards of sustainable, equitable, and longevity-focused health systems.
SuperConvergence Innovation Labs
Lab A:
Systems Medicine & Omics Integration
Genomics, transcriptomics, proteomics, metabolomics, microbiomics
Epigenomics and environmental health
Pharmagenomics and personalized therapeutics
Real-world evidence integration and systems modeling
Application: Advisory evaluation of integrated molecular health strategies.
Lab B:
Digital, Wearable & Augmented Health Monitoring
IoT in medicine: sensors, mobile devices, and smart implants
AI-assisted diagnostics and predictive modeling
Virtual care, smart hospitals, and telehealth
AR/VR, smart glasses, and medical education of the future
Application: Advisory design of patient-centered, data-driven digital lifecare platforms.
Lab C:
Innovation, Regulation & Ethics in Translational Science
Ethics of human enhancement, gene editing (CRISPR), robotics, and nanomedicine
Governance of dual-use and high-risk emerging tech
Institutional review boards (IRBs) and scientific due diligence
Regulation of digital therapies, health apps, and AI
Application: Build advisory frameworks for regulatory alignment and societal accountability.
Capstone Project: Scientific Foresight & Governance Brief
Participants create a board-level report addressing a transformative scientific issue, such as:
Framework for integrating multiomics into public health
Strategic roadmap for healthy longevity medicine implementation
Scientific advisory position on global digital health equity
Ethical guidance on CRISPR and regenerative medicine innovation
Blueprint for a One Health Lifecare knowledge ecosystem
Target Audience
Members of scientific advisory boards across academia, biotech, and policy
Translational science leaders and chief scientific officers
Clinical researchers and precision medicine experts
Global health and One Health advocates
Advisors to funding bodies, ministries, and health systems
Delivery Model
Hybrid: Leading biomedical innovation hubs (e.g., Heidelberg, Zürich, Boston, Stockholm) and global online formats
Faculty: World-renowned scientists, ethics scholars, technologists, and systems innovators
Interdisciplinary forums, foresight roundtables, and global convergence summits
Outcomes & Certification
Executive Certificate: “Certified Scientific Health Advisor – SuperConvergence & Lifecare Innovation”
Exclusive Alumni Membership in THE HEALTH CAPTAINS CLUB
Entry into the Scientific Convergence Circle and Next Generation Lifecare Science Network
Active participation in consensus papers, foresight initiatives, and international advisory missions
Visibility in leading advisory ecosystems shaping the future of science and society
“WE DON’T KNOW WHAT WE DON’T KNOW”
EXPLORING THE UNEXPLORED
LEADERSHIP FOR EXPLORING SUSTAINABLE HEALTH
“360º NEXT GENERATION SUSTAINABLE VALUE-BASED LIFECARE POWERED BY NEW INNOVATIONS AND NEW TECHNOLOGIES AND THE SUPER-CONVERGENCE IN MEDICINE AND HEALTH SCIENCES NAVIGATING US TOGETHER TOWARDS A SUSTAINABLE HEALTH INDUSTRY”